Provided by Tiger Trade Technology Pte. Ltd.

Avis Budget

189.61
+2.781.49%
Post-market: 190.000.3900+0.21%19:59 EDT
Volume:740.06K
Turnover:139.69M
Market Cap:6.70B
PE:-10.01
High:191.17
Open:187.02
Low:184.05
Close:186.83
52wk High:847.70
52wk Low:85.96
Shares:35.32M
Float Shares:14.77M
Volume Ratio:0.79
T/O Rate:5.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.9354
EPS(LYR):-25.2557
ROE:5800.00%
ROA:2.90%
PB:-1.96
PE(LYR):-7.51

Loading ...

Movement Alert|Avis Budget Group Rises 5.21% in Regular Trading, Upgraded by Barclays to Equal Weight

Market Focus
·
Jun 08

Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion

GlobeNewswire
·
Jun 08

Barclays Upgrades Avis Budget Group to Equalweight From Underweight, Adjusts PT to $160 From $140

MT Newswires Live
·
Jun 08

A Look At Cencora (COR) Valuation After 2026 Guidance Update And New CAR T Distribution Deal

Simply Wall St.
·
Jun 08

What Is the Impact of Rupiah Weakening on Banks?

Tempo
·
Jun 05

Fate Therapeutics Advances Off-the-Shelf CAR-T Autoimmune Pipeline

TIPRANKS
·
Jun 05

3 ASX Dividend Stocks To Consider With Up To 7.5% Yield

Simply Wall St.
·
Jun 05

Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting

GlobeNewswire
·
Jun 04

Sami Corwin Initiates Buy on Kyverna (KYTX) on Differentiated miv-cel Efficacy and Advancing BLA for First Autoimmune CAR T Approval

TIPRANKS
·
Jun 04

Legend Biotech ADRs Climb on Preliminary Study Results for Non-Hodgkin Lymphoma Treatment

Dow Jones
·
Jun 03

Legend Biotech presents preliminary clinical data for LB2501 at EHA Congress

TIPRANKS
·
Jun 02

CSPC Pharma's Pioneering mRNA-LNP Dual-Target CAR-T Cell Therapy Gains Clinical Trial Approval in China

Stock News
·
Jun 02

Avis Budget Issues Additional Senior Notes to Refinance Debt

TIPRANKS
·
Jun 02

Avis Budget Car Rental issues USD 300 million 8% senior notes due 2031

Reuters
·
Jun 02

Legend Biotech presents first-in-human LB2102 results in solid tumors

TIPRANKS
·
Jun 02

Genscript Highlights Legend Biotech’s New CAR-T Data in Oncology Programs

TIPRANKS
·
Jun 01

Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026

GlobeNewswire
·
Jun 01

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026

GlobeNewswire
·
Jun 01

CARsgen Showcases New Satri-cel Data as It Expands Claudin18.2 CAR T Strategy

TIPRANKS
·
Jun 01

Chimeric posts positive early CHM CDH17 CAR-T data in metastatic GI cancers

TIPRANKS
·
Jun 01